Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticaria
<b>Background:</b> The Urticaria Patient Daily Diary (UPDD) assesses patient-reported symptoms (itch, hives, angioedema) and impacts in adults and adolescents with chronic spontaneous urticaria (CSU). <b>Objective:</b> The objective was to adapt the UPDD for caregiver completion for patients ages 2-11 years. <b>Methods:</b> To inform modification of the UPDD, two iterative rounds of hybrid concept-elicitation/cognitive-debriefing interviews were conducted with clinical experts and caregivers of children with CSU recruited <i>via</i> patient organizations in the United States and Canada. After concept elicitation, the participants reviewed a draft UPDD-Caregiver Version with initial modifications for caregiver completion. Data were analyzed by using thematic analysis. <b>Results:</b> Four clinicians and 12 caregivers were interviewed (round 1:4 clinicians, 5 caregivers; round 2:7 caregivers). Key symptoms reported by the caregivers were itch (n = 12), hives (n = 12), and swelling and/or angioedema (n = 7). All four clinicians confirmed itch and hives to be key symptoms in children ages 2-11 years with CSU, with associated angioedema for some. Scratching was confirmed as the key observable sign of itch. Caregiver-reported impacts included waking in the night (n = 10); difficulty getting to sleep (n = 8); and daily life impacts, including activities at school (n = 10), play (n = 8), with family and/or friends (n = 4), and sports (n = 3). After round 1, minor revisions were made to enhance comprehension of the UPDD-Caregiver Version, and an overall symptom severity item was added. Relevance, acceptability, and comprehension of the final measure were confirmed by round 2 participants; no further changes were required. <b>Conclusion:</b> The UPDD-Caregiver Version is a relevant and acceptable measure for caregiver completion to assess symptoms and impacts of CSU in children ages 2-11 years.
Authors
- Michel Erlewyn‐Lajeunesse (ORCID: https://orcid.org/0000-0003-1982-1397)
- Donna D. Gardner (ORCID: https://orcid.org/0000-0001-5541-7397)
- Christel Naujoks (ORCID: https://orcid.org/0000-0002-3799-6521)
- Weily Soong (ORCID: https://orcid.org/0000-0002-2701-7035)
- Karsten Weller (ORCID: https://orcid.org/0000-0003-4437-0313)
- Lauri‐Ann Van der Poel (ORCID: https://orcid.org/0000-0002-1797-3381)
- Diane Whalley
- Elaine Dery
- M.M. Balp
Institutions
- Novartis (Switzerland) (CH)
- Virginia College (US)
- Humboldt-Universität zu Berlin (DE)
- Allergy, Asthma and Clinical Research Center (US)
- Southampton Children's Hospital (GB)
- RTI Health Solutions (US)
- Kensington Health (CA)
- Canadian Anthropology Society (CA)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Allergy and Asthma Proceedings
- Published
- 2025-10-29
- DOI
- https://doi.org/10.2500/aap.2025.46.250062
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00